Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryotherapy for Paclitaxel-Induced Neuropathy in Breast Cancer
NCT02230319Phase 2Unknown
- Sponsor
- Virginia Cancer Specialists
- Start
- Oct 2014
- Primary completion
- Sep 2015
- Countries
- 1
01
Overview
Phase 2, open-label trial in peripheral neuropathy, sponsored by Virginia Cancer Specialists. Primary endpoint: Incidence of grade 2 peripheral neuropathies induced by weekly paclitaxel at 2 years. Status: unknown.
02
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT02230319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02230319.